FLSCNasdaqBlank ChecksFiscal year ends December 31
Frazier Life Sciences Acquisition Corp. II
$10.29−0.06 (-0.58%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Frazier Life Sciences Acquisition Corp. II has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Frazier Life Sciences Acquisition Corp. II filed with the SEC
Frazier Life Sciences Acquisition Corp. II Announces Pricing of $75,000,000 Initial Public Offering
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K